Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-652 add-on in knee osteoarthritis
NCT01444365Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Oct 2011
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in osteoarthritis (OA) comparing ABT-652 NSAID with Placebo NSAID (2 arms). Primary endpoint: Subject's Assessment of Arthritis Pain Intensity at 6 weeks. Started Oct 2011; status: completed.
02
Drugs
ABT-652
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01444365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01444365.